Cargando…

Identification of the Prognostic Signatures of Glioma With Different PTEN Status

The high-grade glioma is characterized by cell heterogeneity, gene mutations, and poor prognosis. The deletions and mutations of the tumor suppressor gene PTEN (5%-40%) in glioma patients are associated with worse survival and therapeutic resistance. Characterization of unique prognosis molecular si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Pei, Meng, Xinyi, Liu, Liqun, Li, Shengzhen, Li, Yang, Ali, Sakhawat, Li, Shanhu, Xiong, Jichuan, Liu, Xuefeng, Li, Shouwei, Xia, Qin, Dong, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317988/ https://www.ncbi.nlm.nih.gov/pubmed/34336645 http://dx.doi.org/10.3389/fonc.2021.633357

Ejemplares similares

Role of Ubiquitination in PTEN Cellular Homeostasis and Its Implications in GB Drug Resistance
por: Xia, Qin, et al.
Publicado: (2020)

Smurf1 silencing restores PTEN expression that ameliorates progression of human glioblastoma and sensitizes tumor cells to mTORC1/C2 inhibitor Torin1
por: Xia, Qin, et al.
Publicado: (2021)

Smurf1 Suppression Enhances Temozolomide Chemosensitivity in Glioblastoma by Facilitating PTEN Nuclear Translocation
por: Dong, Lei, et al.
Publicado: (2022)

Deep Learning Radiomics to Predict PTEN Mutation Status From Magnetic Resonance Imaging in Patients With Glioma
por: Chen, Hongyu, et al.
Publicado: (2021)

Classification of Gliomas and Germinomas of the Basal Ganglia by Transfer Learning
por: Ye, Ningrong, et al.
Publicado: (2022)

Identifying α-KG-dependent prognostic signature for lower-grade glioma based on transcriptome profiles
por: Zhang, Tan, et al.
Publicado: (2022)

Molecular Subtypes and Prognostic Signature of Pyroptosis-Related lncRNAs in Glioma Patients
por: Tanzhu, Guilong, et al.
Publicado: (2022)

A Novel Prognostic Signature Based on Glioma Essential Ferroptosis-Related Genes Predicts Clinical Outcomes and Indicates Treatment in Glioma
por: Yun, Debo, et al.
Publicado: (2022)

Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients
por: Lei, Kunjian, et al.
Publicado: (2021)

Development and validation of cuproptosis-associated prognostic signatures in WHO 2/3 glioma
por: Ye, Zhang, et al.
Publicado: (2022)

Prognostic Value of an Autophagy-Related Five-Gene Signature for Lower-Grade Glioma Patients
por: Guo, Jin-Cheng, et al.
Publicado: (2021)

Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
por: Chen, Yujia, et al.
Publicado: (2022)

Prognostic Value of an Immune-Related Gene Signature in Oral Squamous Cell Carcinoma
por: Zhu, Chao, et al.
Publicado: (2021)

Prognostic value of lactate metabolism-related gene expression signature in adult primary gliomas and its impact on the tumor immune microenvironment
por: Wang, Zhihao, et al.
Publicado: (2022)

A Prognostic Microenvironment-Related Immune Signature via ESTIMATE (PROMISE Model) Predicts Overall Survival of Patients With Glioma
por: Qiu, Huaide, et al.
Publicado: (2020)

A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma
por: Jiang, Cheng, et al.
Publicado: (2023)

Transcriptomic Analysis of Glioma Based on IDH Status Identifies ACAA2 as a Prognostic Factor in Lower Grade Glioma
por: Wu, Chenxing, et al.
Publicado: (2020)

A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma
por: Wang, Guohui, et al.
Publicado: (2021)

Therapeutic Potential of Autophagy in Glioblastoma Treatment With Phosphoinositide 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin Signaling Pathway Inhibitors
por: Xia, Qin, et al.
Publicado: (2020)

A novel 25-ferroptosis-related gene signature for the prognosis of gliomas
por: Peng, Xiaojiang, et al.
Publicado: (2023)

NCAPG as a Novel Prognostic Biomarker in Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022)

Calcium-Related Gene Signatures May Predict Prognosis and Level of Immunosuppression in Gliomas
por: Liu, Peidong, et al.
Publicado: (2022)

MYD88 Is a Potential Prognostic Gene and Immune Signature of Tumor Microenvironment for Gliomas
por: Guo, Qinglong, et al.
Publicado: (2021)

Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma
por: Wang, Minjie, et al.
Publicado: (2021)

A Hypoxia-Associated Prognostic Gene Signature Risk Model and Prognosis Predictors in Gliomas
por: Gao, Feng, et al.
Publicado: (2021)

Immune Infiltration Associated MAN2B1 Is a Novel Prognostic Biomarker for Glioma
por: Lin, Xuelei, et al.
Publicado: (2022)

Prognostic Value and Biological Function of Galectins in Malignant Glioma
por: Zhu, Hongtao, et al.
Publicado: (2022)

A Novel Ferroptosis-Related 4-Gene Prognostic Signature for Cholangiocarcinoma and Photodynamic Therapy
por: Zhang, Zi-jian, et al.
Publicado: (2021)

Construction of a Prognostic Gene Signature Associated with Immune Infiltration in Glioma: A Comprehensive Analysis Based on the CGGA
por: Gong, Xiaoxiang, et al.
Publicado: (2021)

Prognostic Significance and Gene Co-Expression Network of PLAU and PLAUR in Gliomas
por: Li, Junhong, et al.
Publicado: (2022)

Identification of the novel prognostic biomarker, MLLT11, reveals its relationship with immune checkpoint markers in glioma
por: Chen, Long, et al.
Publicado: (2022)

Big Data-Based Identification of Multi-Gene Prognostic Signatures in Liver Cancer
por: Liu, Meiliang, et al.
Publicado: (2020)

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
por: Deng, Xiangyang, et al.
Publicado: (2019)

An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas
por: Xu, Yang, et al.
Publicado: (2020)

Current Opinion on Molecular Characterization for GBM Classification in Guiding Clinical Diagnosis, Prognosis, and Therapy
por: Zhang, Pei, et al.
Publicado: (2020)

LCTL Is a Prognostic Biomarker and Correlates With Stromal and Immune Infiltration in Gliomas
por: Su, Jun, et al.
Publicado: (2019)

A Novel RNA Binding Protein-Related Prognostic Signature for Hepatocellular Carcinoma
por: Huang, Yongbiao, et al.
Publicado: (2020)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma
por: Wen, Jun, et al.
Publicado: (2023)

Comprehensive analysis to identify a novel PTEN-associated ceRNA regulatory network as a prognostic biomarker for lung adenocarcinoma
por: Xin, Rui, et al.
Publicado: (2022)

Application of New Radiosensitizer Based on Nano-Biotechnology in the Treatment of Glioma
por: Xie, Yandong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_miu05uqg8fqrd40hee1vqmdsii